According to the IMARC Group, Electrophysiology (EP) devices refer to several medical equipment used to diagnose and treat numerous cardiological ailments. These devices analyze the electrical impulses of the heart and evaluate abnormal heartbeats. Few of the commonly used EP devices include radiofrequency ablation catheters, pacemakers, implantable cardioverter defibrillators (ICDs), automated external defibrillators (AEDs), microwave and laser ablation systems, etc. EP devices send and receive electrical signals to and from the heart to normalize the heartbeat in case of an emergency. These devices are minimally invasive and help in removing dysfunctional heart tissues that may cause irregular heart rhythms.
Request to get the sample report: https://www.imarcgroup.com/electrophysiology-devices-market/requestsample
The increasing prevalence of arrhythmia and other cardiovascular diseases (CVDs), particularly among the growing geriatric population who are more prone to such medical ailments, is primarily driving the market for EP devices. Furthermore, the rising awareness towards several benefits of EP devices pertaining to minimal risks and higher success rates than the conventionally used devices is also propelling the global market. Additionally, several technological advancements have led to the emergence of cryo-, laser and ultrasound ablation and advanced mapping systems, thereby augmenting the market growth. In the coming years, the introduction of compact and portable devices for residential settings will continue to drive the global market for EP devices.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global electrophysiology devices market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product, indication and end user.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/electrophysiology-devices-market
Breakup by Product:
Treatment Devices
Implantable Cardioverter Defibrillators (ICDs)
Automated External Defibrillators (AEDs)
Pacemakers
CRT-P
CRT-D
Catheters
Others
Diagnostic Devices
Holter Monitoring Devices
Diagnostic Electrophysiology Catheters
Electrocardiograph (ECG)
EP Mapping & Imaging Systems
Insertable Cardiac Monitors (ICM)
Others
Breakup by Indication:
Atrial Fibrillation (AF)
Supraventricular Tachycardia
Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
Wolff-Parkinson-White Syndrome (WPW)
Bradycardia
Other
Breakup by End User:
Hospitals
Diagnostic Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Biosense Webster Inc. (Johnson & Johnson), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiofocus Inc., Koninklijke Philips N.V., Medtronic Inc., MicroPort Scientific Corporation, Molecular Devices LLC ( Danaher Corporation), Nihon Kohden Corporation, Siemens Healthcare GmbH and Stereotaxis Inc.
Browse Related Report
https://www.imarcgroup.com/pizza-crust-market
https://www.imarcgroup.com/frozen-pizza-market
https://www.imarcgroup.com/india-organic-milk-market
https://www.imarcgroup.com/testing-commissioning-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
Email: sales@imarcgroup.com
Phone No: (D) +91 120 433 0800 | www.imarcgroup.com
Americas :- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331